United Therapeutics Chairperson, CEO Martine A. Rothblatt disposes of USD 4.3 million in common shares
Bitget2026/10/13 20:31- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $117.76 on Oct. 9, 2026.
- Family trust sold 9,099 shares at prices from $531.92 to $550.7197 on the same day.
- Trust’s common stock stake ended at 324,443 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hedged return rate approaches 6.5%! BNP Paribas Asset Management increases allocation in ultra-long Japanese bonds, as foreign capital bets on curve steepening and domestic demand recovery
BNP Paribas Asset Management has increased its holdings in 20- to 30-year Japanese government bonds, with hedged yields reaching as high as 6.5%. Combined with a stabilized yen and the return of domestic insurance funds, long-term bonds have become the new favorite for global capital.
AI trading weakens, funds return to safe-haven assets, and U.S. Treasury yields hit their lowest level in nearly a month
The outlook for AI trading is being reassessed, reshaping global asset allocation. Stock market pressure is prompting investors to flock to safe-haven assets such as US Treasuries, yen, and Swiss franc. The 30-year US Treasury yield hit 5.38%, the lowest level since September 23. The yen appreciated 0.3% against the US dollar to 157.68, and the Swiss franc rose 0.2%. Safe-haven buying emerged as oil prices surged due to an attack in Saudi Arabia. The future direction will depend on which theme dominates: inflationary pressures or a cooling in AI trading.
AI sell-off suppresses risk appetite, copper prices follow downward
The sell-off in tech stocks has dampened risk appetite, leading to a decline in copper prices.

Japanese Yen: Range trading with upside medium term risk against US Dollar – UOB
